Literature DB >> 28815541

Long Noncoding RNAs in Cancer and Therapeutic Potential.

Arun Renganathan1, Emanuela Felley-Bosco2.   

Abstract

Long noncoding RNAs (lncRNAs) are the major elements of the mammalian transcriptome that is emerging as a central player controlling diverse cellular mechanisms. Most of the well-studied lncRNAs so far are found to be crucial in regulating cellular processes such as cell cycle, growth, and apoptosis that ensure homeostasis. Owing to their location and distribution in the genome, lncRNAs influence the transcription of a wide range of proteins directly or indirectly by transcriptional and posttranscriptional alterations, which opens up the "LncRNA-cancer paradigm" in a context-dependent manner, i.e., either oncogenic or tumor suppressive. Thus, this chapter is a consolidation of lncRNA association in exhibiting or suppressing the typical cancer hallmarks such as continuous proliferation, surpassing apoptosis, genomic instability, drug resistance, invasion, and metastasis studied till date. In addition, special focus has been given on the efficient application of lncRNAs as potential targets for therapeutics that holds a great promise for future cancer therapy.

Entities:  

Keywords:  Antisense oligonucleotides; Cancer; Chemoresistance; Epigenetic regulation; Gene regulation; Natural antisense transcripts; Therapeutic target; ceRNA

Mesh:

Substances:

Year:  2017        PMID: 28815541     DOI: 10.1007/978-981-10-5203-3_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  107 in total

Review 1.  "Clicking" Gene Therapeutics: A Successful Union of Chemistry and Biomedicine for New Solutions.

Authors:  Kira Astakhova; Roslyn Ray; Maria Taskova; Jesper Uhd; Annika Carstens; Kevin Morris
Journal:  Mol Pharm       Date:  2018-02-26       Impact factor: 4.939

Review 2.  Epidrugs: targeting epigenetic marks in cancer treatment.

Authors:  Cristiana Libardi Miranda Furtado; Maria Claudia Dos Santos Luciano; Renan Da Silva Santos; Gilvan Pessoa Furtado; Manoel Odorico Moraes; Claudia Pessoa
Journal:  Epigenetics       Date:  2019-07-13       Impact factor: 4.528

3.  Knocking down LINC01116 can inhibit the regulation of TGF-β through miR-774-5p axis and inhibit the occurrence and development of glioma.

Authors:  Jinfeng Lou; Pengfei Wang; Keliang Chang; Genwei Wang; Xiaoteng Geng; Yang Wu; Wanhong Zhang; Guangming Niu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

4.  ERINA Is an Estrogen-Responsive LncRNA That Drives Breast Cancer through the E2F1/RB1 Pathway.

Authors:  Zihui Fang; Yue Wang; Zehua Wang; Meishu Xu; Songrong Ren; Da Yang; Mei Hong; Wen Xie
Journal:  Cancer Res       Date:  2020-08-21       Impact factor: 12.701

5.  LncRNA KCNQ1OT1 acts as miR-216b-5p sponge to promote colorectal cancer progression via up-regulating ZNF146.

Authors:  Shuang Zhu; Chih-Yen Chen; Yangyang Hao
Journal:  J Mol Histol       Date:  2021-01-04       Impact factor: 2.611

6.  Contributions of HOTAIR polymorphisms to the susceptibility of cancer.

Authors:  Hu-Nian Li; Na Deng; Xu Zhao; Jie Liu; Ting He; Xi-Wei Ding
Journal:  Int J Clin Oncol       Date:  2021-02-25       Impact factor: 3.402

7.  Role of Curcumin in Regulating Long Noncoding RNA Expression in Cancer.

Authors:  Abolfazl Amini; Parand Khadivar; Ali Ahmadnia; Morteza Alipour; Muhammed Majeed; Tannaz Jamialahmadi; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  LINC01433 targets miR-506-3p to promote the biological progress of nasopharyngeal carcinoma cells.

Authors:  Mingguang Zhou; Zhihuai Dong; Sunhong Hu; Mang Xiao
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-21       Impact factor: 2.503

9.  Downregulation of lncRNA XIST Represses Tumor Growth and Boosts Radiosensitivity of Neuroblastoma via Modulation of the miR-375/L1CAM Axis.

Authors:  Haiyan Yang; Xiao Zhang; Yuehua Zhao; GuoLi Sun; Jian Zhang; Yiwen Gao; Qian Liu; Wenhua Zhang; Hongjin Zhu
Journal:  Neurochem Res       Date:  2020-08-28       Impact factor: 3.996

10.  LncRNA HOTTIP facilitates cell proliferation, invasion, and migration in osteosarcoma by interaction with PTBP1 to promote KHSRP level.

Authors:  Xin-Yu Yao; Jian-Fan Liu; Yi Luo; Xue-Zheng Xu; Jie Bu
Journal:  Cell Cycle       Date:  2021-01-21       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.